If you liked this article you might like

Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma
Merger Buzz Drives Akorn to Top of Health Chart in April
Shortened FDA Advisory Panel Is Bad Omen for Puma Bio's Controversial Breast Cancer Drug
Biotech Premarket Movers: Spectrum, BioCryst, Curis